Hygeia Healthcare Holdings Co., Limited (Stock Code: 6078) announced a profit warning for the year ended December 31, 2025. The company expects revenue of approximately RMB4,000 million to RMB4,050 million, representing a decrease of around 9% to 10% compared to 2024. Net profit is projected to be around RMB140 million to RMB200 million, marking a year-on-year reduction of approximately 66% to 76%—mainly attributed to goodwill impairment related to Etern Group Ltd.

Non-IFRS adjusted net profit is forecast at about RMB450 million to RMB490 million, reflecting a decline of roughly 19% to 25% from the prior year. In contrast, net cash generated from operating activities is anticipated to reach approximately RMB940 million to RMB1,000 million, indicating an increase of around 33% to 41% compared to 2024.

According to the announcement, revenue declines and lower profit performance were largely influenced by industry and macro-economic headwinds, in addition to start-up costs and increased depreciation and amortization from newly opened hospitals. The goodwill impairment is described as a one-off accounting adjustment with no material effect on ongoing operations or cash flow. The company’s bank debt as of December 31, 2025, decreased by approximately RMB340 million compared with the previous year, and capital expenditure fell by about 16% to 24%.

The statement highlights stable industry policies and market conditions in the second half of 2025, which contributed to revenue and patient visit growth compared to the first half of the year. Official annual results for 2025 are expected to be published by the end of March 2026, pending final review by auditors.